In this study, IGF2BP3, METTL14, and METTL16 are the key molecules that affect the prognosis of NB patients (IGF2BP1/2/3); insulin-like growth factor-2 (IGF2) mRNA binding protein is the latest reported m6A reader family. The gene discussed is IGF2; the disease is neuroblastoma.